These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 25428263)
1. A 3-microRNA scoring system for prognostication in de novo acute myeloid leukemia patients. Chuang MK; Chiu YC; Chou WC; Hou HA; Chuang EY; Tien HF Leukemia; 2015 May; 29(5):1051-9. PubMed ID: 25428263 [TBL] [Abstract][Full Text] [Related]
2. The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia. Díaz-Beyá M; Brunet S; Nomdedéu J; Cordeiro A; Tormo M; Escoda L; Ribera JM; Arnan M; Heras I; Gallardo D; Bargay J; Queipo de Llano MP; Salamero O; Martí JM; Sampol A; Pedro C; Hoyos M; Pratcorona M; Castellano JJ; Nomdedeu M; Risueño RM; Sierra J; Monzó M; Navarro A; Esteve J Blood Cancer J; 2015 Oct; 5(10):e352. PubMed ID: 26430723 [TBL] [Abstract][Full Text] [Related]
3. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia. Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147 [TBL] [Abstract][Full Text] [Related]
4. Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia. Jinlong S; Lin F; Yonghui L; Li Y; Weidong W PLoS One; 2015; 10(2):e0118099. PubMed ID: 25646775 [TBL] [Abstract][Full Text] [Related]
5. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia. Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705 [TBL] [Abstract][Full Text] [Related]
6. A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia. Zhu R; Zhao W; Fan F; Tang L; Liu J; Luo T; Deng J; Hu Y Oncotarget; 2017 Jun; 8(24):38902-38913. PubMed ID: 28473658 [TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene. Díaz-Beyá M; Navarro A; Ferrer G; Díaz T; Gel B; Camós M; Pratcorona M; Torrebadell M; Rozman M; Colomer D; Monzo M; Esteve J Leukemia; 2013 Mar; 27(3):595-603. PubMed ID: 23022987 [TBL] [Abstract][Full Text] [Related]
8. An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype. Chuang MK; Chiu YC; Chou WC; Hou HA; Tseng MH; Kuo YY; Chen Y; Chuang EY; Tien HF Oncotarget; 2015 Nov; 6(36):39098-110. PubMed ID: 26517675 [TBL] [Abstract][Full Text] [Related]
9. A 4-microRNA signature for survival prognosis in pediatric and adolescent acute myeloid leukemia. Zhu R; Lin W; Zhao W; Fan F; Tang L; Hu Y J Cell Biochem; 2019 Mar; 120(3):3958-3968. PubMed ID: 30242879 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia. Tang X; Chen L; Yan X; Li Y; Xiong Y; Zhou X Med Sci Monit; 2015 Nov; 21():3427-33. PubMed ID: 26549593 [TBL] [Abstract][Full Text] [Related]
11. Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia. Yang DQ; Zhou JD; Wang YX; Deng ZQ; Yang J; Yao DM; Qian Z; Yang L; Lin J; Qian J Int J Lab Hematol; 2017 Feb; 39(1):42-50. PubMed ID: 27577964 [TBL] [Abstract][Full Text] [Related]
12. De Novo Acute Myeloid Leukemia in Adults: Suppression of MicroRNA-223 is Independent of LMO2 Protein Expression BUT Associate With Adverse Cytogenetic Profile and Undifferentiated Blast Morphology. Akhter A; Patel JL; Farooq F; Qureshi A; Taher-Rad MS; Elyamany G; Al-Zahrani AM; Rashid-Kolvear F; Mansoor A Appl Immunohistochem Mol Morphol; 2015; 23(10):733-9. PubMed ID: 25710580 [TBL] [Abstract][Full Text] [Related]
13. MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia. Ma QL; Wang JH; Yang M; Wang HP; Jin J J Transl Med; 2018 Mar; 16(1):68. PubMed ID: 29540187 [TBL] [Abstract][Full Text] [Related]
15. Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients. Tsai CH; Yao CY; Tien FM; Tang JL; Kuo YY; Chiu YC; Lin CC; Tseng MH; Peng YL; Liu MC; Liu CW; Yao M; Lin LI; Chou WC; Chen CY; Hou HA; Tien HF EBioMedicine; 2019 Feb; 40():240-250. PubMed ID: 30662003 [TBL] [Abstract][Full Text] [Related]
16. Down-Regulation of miR-186 Correlates with Poor Survival in de novo Acute Myeloid Leukemia. Zhang TJ; Wang YX; Yang DQ; Yao DM; Yang L; Zhou JD; Deng ZQ; Wen XM; Guo H; Ma JC; Lin J; Qian J Clin Lab; 2016; 62(1-2):113-20. PubMed ID: 27012040 [TBL] [Abstract][Full Text] [Related]
17. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia. Lin X; Wang Z; Wang Y; Feng W Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789 [TBL] [Abstract][Full Text] [Related]
18. Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients. Butrym A; Rybka J; Baczyńska D; Tukiendorf A; Kuliczkowski K; Mazur G J Exp Clin Cancer Res; 2015 Jul; 34(1):68. PubMed ID: 26126974 [TBL] [Abstract][Full Text] [Related]
19. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia. Liu L; Chen R; Zhang Y; Fan W; Xiao F; Yan X Diagn Pathol; 2015 Jul; 10():109. PubMed ID: 26185105 [TBL] [Abstract][Full Text] [Related]
20. The prognostic relevance of miR-212 expression with survival in cytogenetically and molecularly heterogeneous AML. Sun SM; Rockova V; Bullinger L; Dijkstra MK; Döhner H; Löwenberg B; Jongen-Lavrencic M Leukemia; 2013 Jan; 27(1):100-6. PubMed ID: 22692398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]